Imaging Diagnostic Systems Announces Appointment of New CEO and Director


For Immediate Release
Fort Lauderdale, Florida, July 13, 2004--Imaging Diagnostic Systems, Inc.,
(OTCBB:IMDS), an industry leader in the field of Medical Optical Imaging, which
has developed a patented breast-imaging system that utilizes state-of-the-art
laser technology and proprietary algorithms to create three-dimensional
cross-sectional images of the breast for the detection of cancer, announced
today that Tim Hansen was appointed by the Board of Directors to serve as the
new Chief Executive Officer and Board member. IDSI conducted a three-month
search after Linda B. Grable, founder and CEO retired on April 15, 2004.

Mr. Hansen has served in top-level executive positions in the medical imaging
industry over a 30-year period and was notably President of Picker Medical
Systems, a leading company in the diagnostic imaging market. As President of
Picker, he led the $1.2 billion group to improve market share and profitability
in the global equipment and service business. In particular, he increased the CT
scanner business via technology developments to fuel Picker's overall profit
growth.

Most recently, Mr. Hansen was with Cardinal Health, Inc. as the general manager
of the Radiation Management Services, a leading provider of medical imaging
quality assurance instruments and solutions. He brings executive-level
experience, managing business operations, global marketing and sales, technology
development, and developing luminary relationships in the diagnostic imaging
field.

"Tim's outstanding track record and well-rounded background in the medical
technology industry will add immediate strength and strategic leadership to
IDSI", states Jay Bendis, Co-Chairman of the Board. Mr. Bendis also added, "We
are fortunate to have attracted an executive of Mr. Hansen's caliber and vision
to lead the company at this stage of its global commercialization growth. Mr.
Hansen comes to the IDSI team with enthusiasm, strong leadership skills, and
diverse experience that will both position IDSI as an industry leader and
increase shareholder value.

"I am excited about the unique IDSI technology and the possibilities it presents
to improve the diagnosis of breast cancer. I look forward to working with the
IDSI scientists, the clinical team and our development partners to guide the
Company to full realization of this important adjunct to mammography," stated
Tim Hansen.

Please visit  Imaging  Diagnostic  Systems'  website at:  www.imds.com  for
additional information.

Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian
License, UL listing, ISO 9001:2000-13488 certification and FDA export
certification for its CT Laser Breast imaging system. The CTLM(R) system is the
first patented breast-imaging system that utilizes state-of the-art laser
technology and patented algorithms to create 3-D cross- sectional images of the
breast. The Company is seeking PreMarket Approval (PMA) from the Food and Drug
Administration (FDA) for its CTLM(R) system to be used as an adjunct to
mammography. The CTLM(R) system is a non-invasive, painless examination that
does not expose the patient to radiation nor require breast compression.

In conjunction with the provisions of the Safe Harbor section of the Private
Securities Litigation Reform Act of 1995, this news release may contain
forward-looking statements pertaining to future anticipated projected plans,
performances and developments, as well as other statements relating to future
operations. All such forward-looking statements are necessarily only estimates
of future results and there can be no assurance that actual results will not
materially differ from expectation. Further information on potential factors
that could affect Imaging Diagnostic Systems, Inc., is included in the Company's
filing with the Securities and Exchange Commission.



Investor Relations:                        Public Relations:
Rick Lutz                                  Margie Adelman
404-261-1196                               561-347-6768
lcgroup@mindspring.com                     madelman@adelmancommunicatins.com